TABLE 1.
Demographics
| N | INFXN | NORMAL | ACR | P |
|---|---|---|---|---|
| 26 | 30 | 13 | ||
| SLT | 2 | 2 | 2 | |
| BLT | 24 | 28 | 11 | 0.99 |
| Months post-LT | 1.75±5.0 | 1.25±6.5 | 1.0±2.3 | |
| Age (y) | 35±15 | 44±15 | 52±16 | 0.84 |
| Gender (male) | 52% | 64% | 46% | |
| Ethnicity | ||||
| Caucasian (%) | 96 | 80 | 92 | |
| Hispanic (%) | 0 | 0 | 8 | |
| Asian (%) | 4 | 10 | 0 | |
| African American (%) | 0 | 10 | 0 | |
| Native diagnoses: | ||||
| COPD (%) | 31 | 33 | 46 | |
| CF (%) | 31 | 23 | 15 | |
| ILD (%) | 23 | 23 | 31 | |
| PAH (%) | 8 | 13 | 0 | |
| Other (%) | 7 | 8 | 8 | |
There were no statistical differences across cohorts.
Kruskal-Wallis 1-way ANOVA on ranks; P < 0.05.
ACR, acute cellular rejection; BLT, bilateral lung transplant; CF, cystic fibrosis; COPD, chronic obstructive pulmonary diseases; ILD, interstitial lung diseases; LT, lung transplant; PAH, pulmonary arterial hypertension; SLT, single lung transplant.